Home
/ Taejoon
/ Competitors

Taejoon Competitors and Similar CompaniesClear all

Taejoon's competitors and similar companies include Almac Group, Dong-A Socio Holdings, Jubilant Radiopharma and Rational Vaccines.

	Taejoon Taejoon is a pharmaceutical company.	Almac Group Almac Group is a company that provides a range of services across the drug development lifecycle.	Dong-A Socio Holdings Dong-A Socio Holdings (동아쏘시오홀딩스, also known as Dong-A ST) is a company that manufactures and sells pharmaceuticals.	Jubilant Radiopharma Jubilant Radiopharma (also known as Jubilant DraxImage) is a company that provides pharmaceutical solutions.	Rational Vaccines Rational Vaccines is a company developing a vaccine for herpes.
Founding Date	Founding Date 1978	Founding Date 2002	Founding Date 1932	Founding Date 1955	Founding Date 2015
Type	Type Private	Type Subsidiary	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare drug development medical diagnostics pharma	Tags Healthcare chemicals clinical research drug development pharma	Tags Healthcare drug development medical diagnostics pharma	Tags Healthcare drug development medical diagnostics pharma	Tags Healthcare drug development medical diagnostics pharma
Locations	Locations HQ	Locations Craigavon, GB HQ Athlone, IE Dundalk, IE Minato City, JP Singapore, SG Alderley Edge, GB Belfast, GB see more	Locations Seoul, KR HQ Sao Paulo, BR Cerritos, US	Locations Kirkland, CA HQ Noida, IN	Locations Cambridge, US HQ Woburn, US
Employees	Employees 52	Employees 4,7021% increase	Employees 922% increase	Employees 1381% increase	Employees 12
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) £735.1m (FY, 2021)	Revenue (est.) ₩1.4t (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods £474.7m (FY, 2021)	Cost of goods ₩894.9b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit £260.3m (FY, 2021)	Gross profit ₩542.4b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income £64.2m (FY, 2021)	Net income ₩91.5b (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 1m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 8.9m